The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitroTomer M. Yaron, Nicholas S. Heaton|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 63
TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2Joseph D. Trimarco, Nicholas S. Heaton|PLoS Pathogens|2021Cited by 62
Approaches for timeline reductions in pathogenesis studies using genetically modified miceSamantha Skavicus, Nicholas S. Heaton|Microbiology Spectrum|2023Cited by 9